Movement Alert|INSILICO Falls 5.37% in Regular Trading, AI Pharma Sector Correction Weighs on Stock

Market Focus
Yesterday

On October 13, INSILICO fell 5.37% in regular trading, trading at HK$44.52/share, with Turnover of HK$99.31 million.

The decline was driven by broad-based profit-taking across the AI pharmaceutical sector, with funds continuing to lock in gains from the prior rally. JPMorgan's reduction of its stake in INSILICO on October 6, lowering its long position from 6.13% to 5.96%, further dampened market sentiment.

Separately, INSILICO announced the nomination of its 35th preclinical candidate, ISM9546, an oral, peripherally restricted VAV1 molecular glue degrader for autoimmune diseases, discovered via its Pharma.AI platform. Within the Life Sciences Tools & Services sector, Genscript Bio fell 9.92%, Wuxi Bio down 3.23%, Wuxi Apptec down 1.92%, Xtalpi down 4.86%, and Wuxi XDC down 3.76%.

INSILICO is engaged in AI-driven drug discovery and pipeline development, with assets generated through its proprietary Pharma.AI platform spanning clinical and IND-stage programs, along with software solutions and other non-pharmaceutical R&D businesses.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10